Avanos Medical Inc
AVNS11.410USD
+0.010+0.09%
Cierre 12/26, 16:00（ET）Cotizaciones retrasadas 15 min
529.62MCap. mercado
PérdidaP/E TTM
Más Datos de Avanos Medical Inc Compañía
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Información de Avanos Medical Inc
Símbolo de cotizaciónAVNS
Nombre de la empresaAvanos Medical Inc
Fecha de salida a bolsaOct 21, 2014
Director ejecutivoPacitti (David)
Número de empleados2227
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 21
Dirección5405 Windward Parkway
CiudadALPHARETTA
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal30004
Teléfono18444282667
Sitio Webhttps://avanos.com/
Símbolo de cotizaciónAVNS
Fecha de salida a bolsaOct 21, 2014
Director ejecutivoPacitti (David)
Ejecutivos de Avanos Medical Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
242.05K
--
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
91.59K
+27.94%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Vice President - Corporate Finance, Treasurer
Vice President - Corporate Finance, Treasurer
--
--
Ms. Indrani L. Franchini, J.D.
Ms. Indrani L. Franchini, J.D.
Independent Director
Independent Director
--
--
Mr. Scott Galovan
Mr. Scott Galovan
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--
Ms. Camille Chang Gilmore
Ms. Camille Chang Gilmore
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
242.05K
--
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
91.59K
+27.94%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Vice President - Corporate Finance, Treasurer
Vice President - Corporate Finance, Treasurer
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Digestive Health
102.70M
62.74%
Pain Management
61.00M
37.26%
Por regiónUSD
Nombre
Ganancia
Proporción
North America
138.50M
84.61%
Europe, Middle East and Africa
22.80M
13.93%
Asia Pacific and Latin America
13.70M
8.37%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Digestive Health
102.70M
62.74%
Pain Management
61.00M
37.26%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.24%
T. Rowe Price Investment Management, Inc.
10.15%
The Vanguard Group, Inc.
7.24%
Armistice Capital LLC
5.39%
Dimensional Fund Advisors, L.P.
5.07%
Otro
58.91%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.24%
T. Rowe Price Investment Management, Inc.
10.15%
The Vanguard Group, Inc.
7.24%
Armistice Capital LLC
5.39%
Dimensional Fund Advisors, L.P.
5.07%
Otro
58.91%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
48.44%
Investment Advisor/Hedge Fund
27.84%
Hedge Fund
16.02%
Individual Investor
4.09%
Research Firm
2.80%
Family Office
1.97%
Pension Fund
1.24%
Bank and Trust
0.47%
Sovereign Wealth Fund
0.05%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
599
44.88M
113.89%
+5.76K
2025Q3
617
45.01M
114.39%
-81.05K
2025Q2
610
45.14M
115.30%
+1.07M
2025Q1
615
44.04M
105.94%
-4.70M
2024Q4
596
44.47M
105.92%
+325.84K
2024Q3
583
44.12M
104.92%
+568.23K
2024Q2
585
43.69M
107.04%
-931.37K
2024Q1
593
44.72M
107.68%
-5.03M
2023Q4
601
45.14M
107.42%
+359.77K
2023Q3
598
44.92M
104.35%
-994.38K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
6.23M
13.43%
-169.53K
-2.65%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.00M
8.61%
+238.94K
+6.36%
Jun 30, 2025
The Vanguard Group, Inc.
4.40M
9.49%
-883.40K
-16.71%
Jun 30, 2025
Armistice Capital LLC
2.04M
4.39%
+36.00K
+1.80%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.58M
5.56%
-17.29K
-0.67%
Jun 30, 2025
Brown Advisory
1.81M
3.9%
-122.33K
-6.33%
Jun 30, 2025
State Street Investment Management (US)
1.92M
4.13%
-11.80K
-0.61%
Jun 30, 2025
D. E. Shaw & Co., L.P.
1.19M
2.57%
+102.95K
+9.45%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.07M
2.31%
-2.50K
-0.23%
Jun 30, 2025
AQR Capital Management, LLC
560.05K
1.21%
+367.19K
+190.39%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Equipment ETF
0.8%
Invesco S&P SmallCap 600 Pure Value ETF
0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.37%
Invesco S&P SmallCap Health Care ETF
0.32%
Royce Quant Small-Cap Quality Value ETF
0.31%
Harbor Human Capital Factor US Small Cap ETF
0.22%
Vanguard US Value Factor ETF
0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.13%
Fidelity Enhanced Small Cap ETF
0.13%
Pacer US Small Cap Cash Cows ETF
0.09%
Ver más
State Street SPDR S&P Health Care Equipment ETF
Proporción0.8%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción0.37%
Invesco S&P SmallCap Health Care ETF
Proporción0.32%
Royce Quant Small-Cap Quality Value ETF
Proporción0.31%
Harbor Human Capital Factor US Small Cap ETF
Proporción0.22%
Vanguard US Value Factor ETF
Proporción0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporción0.13%
Fidelity Enhanced Small Cap ETF
Proporción0.13%
Pacer US Small Cap Cash Cows ETF
Proporción0.09%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Avanos Medical Inc?
Los cinco principales accionistas de Avanos Medical Inc son:
BlackRock Institutional Trust Company, N.A. posee 6.23M acciones, lo que representa el 13.43% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 4.00M acciones, lo que representa el 8.61% del total de acciones.
The Vanguard Group, Inc. posee 4.40M acciones, lo que representa el 9.49% del total de acciones.
Armistice Capital LLC posee 2.04M acciones, lo que representa el 4.39% del total de acciones.
Dimensional Fund Advisors, L.P. posee 2.58M acciones, lo que representa el 5.56% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 6.23M acciones, lo que representa el 13.43% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 4.00M acciones, lo que representa el 8.61% del total de acciones.
The Vanguard Group, Inc. posee 4.40M acciones, lo que representa el 9.49% del total de acciones.
Armistice Capital LLC posee 2.04M acciones, lo que representa el 4.39% del total de acciones.
Dimensional Fund Advisors, L.P. posee 2.58M acciones, lo que representa el 5.56% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Avanos Medical Inc?
Los tres principales tipos de accionista de Avanos Medical Inc son:
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
¿Cuántas instituciones poseen acciones de Avanos Medical Inc (AVNS)?
A fecha de 2025Q4, 599 instituciones poseen acciones de Avanos Medical Inc, con un valor de mercado combinado de aproximadamente 44.88M, lo que representa el 113.89% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.51%.
¿Cuál es la mayor fuente de ganancias de Avanos Medical Inc?
El FY2025Q2, el segmento empresarial Digestive Health generó la ganancia más alta para Avanos Medical Inc, ascendiendo a 102.70M y representando el 62.74% de la ganancia total.
